What is Neurable?
Neurable Inc., based in Massachusetts, is at the forefront of neurotechnology, specializing in the development of AI-driven tools for brain signal translation and BCI. Leveraging patented signal processing techniques refined through extensive research and a team of leading scientists and product experts, Neurable's AI platform facilitates high-performance BCI integration into common devices. The company is committed to creating a world where individuals can transcend physical and cognitive barriers with advanced neurotechnology solutions.
How much funding has Neurable raised?
Neurable has raised a total of $56.1M across 5 funding rounds:
Angel/Seed
$2M
Series A
$6M
Debt
$150K
Other Financing Round
$13M
Series A
$35M
Angel/Seed (2016): $2M with participation from NXT Ventures, Point Judith Capital, and The Kraft Group
Series A (2019): $6M led by M Ventures, Innospark Ventures, Loup Ventures, Zell Lurie Commercialization Fund, and Point Judith Capital
Debt (2020): $150K supported by PPP
Other Financing Round (2024): $13M featuring Metaplanet, Ultratech Capital Partners, and Pace Ventures
Series A (2025): $35M, investors not publicly disclosed
Key Investors in Neurable
Metaplanet
Metaplanet is an early-stage investment firm that focuses on backing mission-driven founders working on positively disruptive deep technologies. The firm prioritizes long-term investments in tech that supports humanity's survival and fosters a positive societal impact.
Ultratech Capital Partners
Ultratech Capital Partners invests in early-stage companies developing innovative 'dual use' technologies that address global challenges and are critical to national security. The firm focuses on sectors such as AI, cybersecurity, semiconductors, and energy.
Pace Ventures
Pace Ventures is a group of entrepreneurs and venture builders who see innovation as the only way to drive progress in business, utilizing tools like hackathons, incubators, and accelerators.
What's next for Neurable?
With the recent influx of major strategic investment, Neurable is poised for significant expansion and further development of its AI-powered BCI platform. This capital infusion, part of its $56.2M in total funding, will likely fuel advancements in product development, research into new applications for brain signal translation, and the scaling of its operations to meet growing market demand. The company's focus on enabling individuals to overcome limitations through neurotechnology suggests a strategic direction towards broader consumer and medical device integration, potentially solidifying its position as a leader in the burgeoning BCI market.
See full Neurable company page
